ExecEdge

Eliem Therapeutics Changes Name to Climb Bio

Eliem Therapeutics Changes Name to Climb Bio

By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be Climb Bio, Inc. and it will start trading at Nasdaq...

John McEntee’s @daterightstuff TikTok Provides A Window Into The Future of Political Communications, Business Development

John McEntee’s @daterightstuff TikTok Provides A Window Into The Future of Political Communications, Business Development

Aktis Oncology Unveils $175M Series B Financing to Advance Proprietary Radio Pharma

Aktis Oncology Unveils $175M Series B Financing to Advance Proprietary Radio Pharma

Vivani Medical to Test Implant in Obese and Overweight Patients

Vivani Medical to Test Implant in Obese and Overweight Patients

How EquitiesFirst Could Free Up Capital for Investment in Clean Energy in China

How EquitiesFirst Could Free Up Capital for Investment in Clean Energy in China

INTERVIEW: Dutch Bros Raises Guidance as Profit Doubles, Chooses Christine Barone as Next CEO

INTERVIEW: Dutch Bros Raises Guidance as Profit Doubles, Chooses Christine Barone as Next CEO

Unleashing the Power of AI: HistoIndex Redefines NASH Clinical Trials with Stain-Free Tissue Imaging at EASL Congress 2023

Unleashing the Power of AI: HistoIndex Redefines NASH Clinical Trials with Stain-Free Tissue Imaging at EASL Congress 2023

reAlpha Launches Fractional Ownership Platform for Short-Term Rentals

reAlpha Launches Fractional Ownership Platform for Short-Term Rentals

Hear from J. Michael Prince, CEO of USPAGL Live at ICR Conference

Hear from J. Michael Prince, CEO of USPAGL Live at ICR Conference

Grove Collaborative Holdings Issues FY23 Guidance

Grove Collaborative Holdings Issues FY23 Guidance

Sirnaomics Publishes Research on Cancer Drug Candidate

Sirnaomics Publishes Research on Cancer Drug Candidate

Input your search keywords and press Enter.